Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 1
1989 3
1993 2
1994 3
1995 1
1996 2
1997 1
2000 2
2001 1
2002 4
2003 2
2004 4
2005 2
2006 6
2007 3
2008 2
2009 3
2010 2
2011 5
2012 7
2013 7
2014 3
2015 5
2016 9
2017 6
2018 5
2019 3
2020 3
2021 4
2022 6
2023 5
2024 3
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ, Chew LP, Bee PC, Lim SM, Lu MY, Tantiworawit A, Ganeva P, Gercheva L, Shah F, Neufeld EJ, Thompson A, Laadem A, Shetty JK, Zou J, Zhang J, Miteva D, Zinger T, Linde PG, Sherman ML, Hermine O, Porter J, Piga A; BELIEVE Investigators. Cappellini MD, et al. Among authors: khelif a. N Engl J Med. 2020 Mar 26;382(13):1219-1231. doi: 10.1056/NEJMoa1910182. N Engl J Med. 2020. PMID: 32212518 Clinical Trial.
Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trial.
Cappellini MD, Viprakasit V, Georgiev P, Coates TD, Origa R, Khelif A, Liew HK, Tantiworawit A, Chew LP, Khalil A, Ho PJ, Kuo KHM, Holot N, Perin M, Giuseppi AC, Kuo WL, Lai Y, Medlin LF, Bueno LM, Kattamis A, Taher AT. Cappellini MD, et al. Among authors: khelif a. Lancet Haematol. 2025 Mar;12(3):e180-e189. doi: 10.1016/S2352-3026(24)00376-4. Epub 2025 Feb 10. Lancet Haematol. 2025. PMID: 39947215 Clinical Trial.
REACH: A programme for improving care in haemophilia.
Goga Y, Boukari R, Bensadok M, El Khorassani M, Khelif A, Al Rawas A, Alkasim F, Shaheen NM, Negrier C. Goga Y, et al. Among authors: khelif a. Haemophilia. 2019 May;25(3):e211-e215. doi: 10.1111/hae.13726. Epub 2019 Mar 19. Haemophilia. 2019. PMID: 30888109 No abstract available.
Evidence of a broadband gap in a phononic crystal strip.
Coffy E, Euphrasie S, Addouche M, Vairac P, Khelif A. Coffy E, et al. Among authors: khelif a. Ultrasonics. 2017 Jul;78:51-56. doi: 10.1016/j.ultras.2017.03.003. Epub 2017 Mar 6. Ultrasonics. 2017. PMID: 28319820
Sexual function outcomes in men undergoing minimal invasive ablative techniques for prostate cancer: a ESRU/YAU urotech systematic review and pooled analysis.
Piramide F, Veccia A, Tzelves L, Nikles S, Ortega Polledo LE, Nocera L, Khelif A, Dumbovic L, Lazarou L, Cisero E, Quarà A, Sterrantino A, Falagario U, Piazza P, Baekealndt L, Carrion DM, Gomez Rivas J, Cacciamani G, Checcucci E. Piramide F, et al. Among authors: khelif a. Minerva Urol Nephrol. 2025 Jun;77(3):285-297. doi: 10.23736/S2724-6051.25.06007-0. Minerva Urol Nephrol. 2025. PMID: 40528769
Multiple myeloma following essential thrombocythemia.
Ben Youssef Y, Gmidène A, Bouabid Z, Bouallegui S, Sriha B, Zaier M, Sennana H, Khelif A. Ben Youssef Y, et al. Among authors: khelif a. Ann Biol Clin (Paris). 2013 Jul-Aug;71(4):457-60. doi: 10.1684/abc.2013.0856. Ann Biol Clin (Paris). 2013. PMID: 23906574 Free article. Review.
107 results